Past Director: Jerry R. McGhee, PhD
Co-Directors: David Briles, PhD;
Kohtaro Fujihashi, DDS, PhD; Hiroshi Kiyono, DDS, PhD;
Jiri Mestecky, MD
Established: 1990
The
mission of the Immunobiology Vaccine Center (IVC) is
to foster vaccine research at UAB with an emphasis on mucosal vaccine
development. The Center currently has 35
appointed faculty representing 6 departments and 2 schools at UAB.
Center Research
The
Center’s basic research examines the role of T helper cells in mucosal
immunity, cytokines/chemokines as adjuvants
for mucosal immunity, development of non-toxic mucosal adjuvants,
and vaccines for respiratory bacterial pathogens.
Clinical research includes preclinical
studies on the safety of enterotoxin-derived mucosal adjuvants and analysis of immunity to Pneumococci
in humans. Recently, the Center has
initiated a biodefense program for developing mucosal
vaccines to category A agents, since most bioterrorism
attacks would likely occur via airborne or enteric (water-borne) routes.
The IVC accepts positions for postdoctoral fellows for their career development based upon the availability of funds.
For additional
information:
Past Director: Jerry R. McGhee, PhD
Email: mcghee@uab.edu
Phone: 205-934-5045
Co-Director: Kohtaro
Fujihashi, DDS, PhD
Email: kohtarof@uab.edu
Phone: 205-934-1951
Administrator: Sheila Turner
Email: jordan@uab.edu
Phone: 205-934-5124
Approved by: Kohtaro Fujihashi, DDS, PhD, Co-Director
Date: April 3, 2008
Click here to return to the SOM
Research Web Site's home page.